Cian McCarthy, Mb.Bch,Bao
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Infarction | 34 | 2024 | 11461 | 4.490 |
Why?
|
Troponin | 9 | 2023 | 502 | 3.060 |
Why?
|
Troponin I | 7 | 2024 | 651 | 2.260 |
Why?
|
Chest Pain | 7 | 2022 | 1091 | 1.650 |
Why?
|
Acute Coronary Syndrome | 9 | 2024 | 2190 | 1.650 |
Why?
|
Morphine | 4 | 2017 | 657 | 1.640 |
Why?
|
Anterior Wall Myocardial Infarction | 2 | 2023 | 42 | 1.600 |
Why?
|
Patient Readmission | 10 | 2021 | 3271 | 1.500 |
Why?
|
Coronary Stenosis | 4 | 2023 | 794 | 1.190 |
Why?
|
Cardiovascular Diseases | 18 | 2024 | 15501 | 0.960 |
Why?
|
Coronary Angiography | 10 | 2023 | 4471 | 0.960 |
Why?
|
International Classification of Diseases | 5 | 2021 | 909 | 0.950 |
Why?
|
Diagnostic Errors | 2 | 2024 | 1265 | 0.940 |
Why?
|
Coronary Artery Disease | 9 | 2023 | 6403 | 0.890 |
Why?
|
Bullying | 2 | 2016 | 232 | 0.830 |
Why?
|
Vasodilator Agents | 2 | 2017 | 973 | 0.790 |
Why?
|
Thrombosis | 4 | 2022 | 2942 | 0.780 |
Why?
|
Medical Staff, Hospital | 2 | 2016 | 601 | 0.770 |
Why?
|
Teaching Rounds | 2 | 2016 | 275 | 0.760 |
Why?
|
Anticoagulants | 6 | 2022 | 4812 | 0.760 |
Why?
|
Platelet Aggregation Inhibitors | 6 | 2022 | 2751 | 0.740 |
Why?
|
Plaque, Atherosclerotic | 2 | 2023 | 1533 | 0.690 |
Why?
|
Economics, Hospital | 2 | 2019 | 210 | 0.680 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2023 | 323 | 0.660 |
Why?
|
Fibrinolytic Agents | 2 | 2018 | 2084 | 0.600 |
Why?
|
Troponin T | 3 | 2023 | 780 | 0.600 |
Why?
|
Antihypertensive Agents | 2 | 2024 | 2024 | 0.590 |
Why?
|
Proteomics | 3 | 2020 | 3848 | 0.570 |
Why?
|
Heart Injuries | 1 | 2019 | 206 | 0.570 |
Why?
|
Health Services Misuse | 1 | 2019 | 244 | 0.560 |
Why?
|
Caricatures as Topic | 1 | 2016 | 1 | 0.550 |
Why?
|
Hypertension | 4 | 2024 | 8540 | 0.540 |
Why?
|
Physicians | 3 | 2020 | 4591 | 0.540 |
Why?
|
Medicare | 6 | 2024 | 6770 | 0.540 |
Why?
|
Natriuretic Peptides | 1 | 2017 | 155 | 0.540 |
Why?
|
Trimetazidine | 1 | 2015 | 2 | 0.530 |
Why?
|
Conflict of Interest | 2 | 2018 | 554 | 0.530 |
Why?
|
Cardiology | 4 | 2022 | 1656 | 0.530 |
Why?
|
Metaphor | 1 | 2016 | 41 | 0.520 |
Why?
|
Patient Care Management | 1 | 2019 | 302 | 0.520 |
Why?
|
Nitrates | 1 | 2017 | 263 | 0.510 |
Why?
|
Program Development | 2 | 2018 | 1297 | 0.500 |
Why?
|
Heart Failure | 7 | 2022 | 11670 | 0.500 |
Why?
|
Humans | 93 | 2024 | 761572 | 0.500 |
Why?
|
Models, Organizational | 1 | 2018 | 546 | 0.490 |
Why?
|
Specialization | 1 | 2020 | 778 | 0.490 |
Why?
|
Health Status Indicators | 1 | 2020 | 970 | 0.480 |
Why?
|
Catheterization, Peripheral | 1 | 2018 | 343 | 0.470 |
Why?
|
Peroxidase | 1 | 2017 | 609 | 0.460 |
Why?
|
Prognosis | 17 | 2024 | 29629 | 0.460 |
Why?
|
Education, Medical | 2 | 2016 | 1725 | 0.460 |
Why?
|
Aortic Valve Stenosis | 2 | 2017 | 2001 | 0.450 |
Why?
|
Reimbursement, Incentive | 1 | 2019 | 543 | 0.450 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2017 | 411 | 0.450 |
Why?
|
Predictive Value of Tests | 10 | 2023 | 15266 | 0.440 |
Why?
|
Metabolic Diseases | 1 | 2020 | 683 | 0.430 |
Why?
|
Warfarin | 2 | 2022 | 1483 | 0.430 |
Why?
|
Blood Proteins | 1 | 2018 | 1173 | 0.420 |
Why?
|
Students, Medical | 2 | 2016 | 1936 | 0.410 |
Why?
|
Heparin | 1 | 2020 | 1634 | 0.410 |
Why?
|
Risk Assessment | 12 | 2020 | 23996 | 0.400 |
Why?
|
Coronary Vessel Anomalies | 1 | 2015 | 307 | 0.400 |
Why?
|
Watchful Waiting | 1 | 2016 | 491 | 0.390 |
Why?
|
Angina Pectoris | 1 | 2015 | 959 | 0.390 |
Why?
|
Sex Factors | 6 | 2021 | 10553 | 0.380 |
Why?
|
C-Reactive Protein | 4 | 2022 | 3826 | 0.380 |
Why?
|
Hospitalization | 4 | 2022 | 10721 | 0.380 |
Why?
|
Heart Diseases | 3 | 2021 | 2781 | 0.380 |
Why?
|
Patient Discharge | 3 | 2020 | 3443 | 0.360 |
Why?
|
Disease Management | 2 | 2018 | 2508 | 0.350 |
Why?
|
Practice Guidelines as Topic | 7 | 2024 | 7391 | 0.340 |
Why?
|
Thrombocytopenia | 1 | 2017 | 1182 | 0.340 |
Why?
|
Information Dissemination | 1 | 2018 | 1126 | 0.340 |
Why?
|
Medicaid | 3 | 2019 | 2818 | 0.330 |
Why?
|
Health Care Reform | 1 | 2018 | 1247 | 0.330 |
Why?
|
Thrombolytic Therapy | 1 | 2018 | 2064 | 0.330 |
Why?
|
Coronary Vessels | 2 | 2021 | 3096 | 0.320 |
Why?
|
Analgesics, Opioid | 4 | 2017 | 3808 | 0.310 |
Why?
|
Heart Valve Prosthesis | 1 | 2017 | 1462 | 0.310 |
Why?
|
Salaries and Fringe Benefits | 2 | 2021 | 257 | 0.310 |
Why?
|
Arrhythmias, Cardiac | 2 | 2024 | 2244 | 0.310 |
Why?
|
United States | 19 | 2024 | 72335 | 0.300 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2019 | 2118 | 0.300 |
Why?
|
Peripheral Arterial Disease | 2 | 2018 | 1273 | 0.290 |
Why?
|
Faculty, Medical | 1 | 2016 | 1204 | 0.290 |
Why?
|
Mitral Valve Insufficiency | 1 | 2017 | 1400 | 0.280 |
Why?
|
Quality of Health Care | 2 | 2018 | 4330 | 0.270 |
Why?
|
Health Policy | 1 | 2018 | 2684 | 0.260 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2016 | 1553 | 0.250 |
Why?
|
Aged | 20 | 2024 | 169310 | 0.240 |
Why?
|
Dyslipidemias | 2 | 2022 | 868 | 0.230 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3530 | 0.230 |
Why?
|
Acute Kidney Injury | 3 | 2022 | 1924 | 0.230 |
Why?
|
Patient Selection | 1 | 2016 | 4244 | 0.220 |
Why?
|
Aspirin | 3 | 2020 | 3133 | 0.220 |
Why?
|
Coronary Disease | 2 | 2017 | 5914 | 0.220 |
Why?
|
Male | 30 | 2024 | 360842 | 0.220 |
Why?
|
Echocardiography | 1 | 2016 | 4989 | 0.220 |
Why?
|
Middle Aged | 21 | 2023 | 220920 | 0.210 |
Why?
|
Survival Analysis | 4 | 2019 | 10090 | 0.210 |
Why?
|
Prospective Studies | 10 | 2023 | 54426 | 0.210 |
Why?
|
Risk Factors | 14 | 2023 | 74213 | 0.200 |
Why?
|
Hospital Mortality | 4 | 2021 | 5293 | 0.200 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3245 | 0.200 |
Why?
|
Female | 29 | 2024 | 392686 | 0.200 |
Why?
|
Incidence | 6 | 2019 | 21355 | 0.190 |
Why?
|
Massachusetts | 3 | 2019 | 8830 | 0.190 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2020 | 1723 | 0.180 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2024 | 506 | 0.180 |
Why?
|
Fellowships and Scholarships | 2 | 2020 | 1117 | 0.180 |
Why?
|
Severity of Illness Index | 5 | 2019 | 15843 | 0.180 |
Why?
|
Emergency Service, Hospital | 3 | 2022 | 7879 | 0.180 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1096 | 0.170 |
Why?
|
Hyperlipoproteinemias | 1 | 2019 | 20 | 0.160 |
Why?
|
Cause of Death | 2 | 2020 | 3683 | 0.160 |
Why?
|
Catheter Ablation | 2 | 2024 | 2751 | 0.150 |
Why?
|
Sus scrofa | 1 | 2020 | 428 | 0.150 |
Why?
|
Peripheral Vascular Diseases | 1 | 2021 | 488 | 0.150 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2019 | 148 | 0.150 |
Why?
|
Insurance, Health | 2 | 2021 | 2498 | 0.150 |
Why?
|
Comorbidity | 3 | 2024 | 10508 | 0.140 |
Why?
|
Drug Therapy, Combination | 2 | 2017 | 6312 | 0.140 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2019 | 361 | 0.140 |
Why?
|
Mendelian Randomization Analysis | 1 | 2023 | 1007 | 0.140 |
Why?
|
Length of Stay | 3 | 2021 | 6426 | 0.140 |
Why?
|
Endothelin-1 | 1 | 2018 | 302 | 0.140 |
Why?
|
Angiography | 2 | 2022 | 1595 | 0.140 |
Why?
|
Apolipoproteins | 1 | 2019 | 326 | 0.140 |
Why?
|
Receptors, Interleukin-1 | 1 | 2018 | 262 | 0.140 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 2243 | 0.140 |
Why?
|
Prevalence | 5 | 2022 | 15732 | 0.140 |
Why?
|
Ischemic Preconditioning, Myocardial | 1 | 2016 | 69 | 0.130 |
Why?
|
Coronary Care Units | 1 | 2018 | 235 | 0.130 |
Why?
|
Drug Labeling | 1 | 2018 | 248 | 0.130 |
Why?
|
Neprilysin | 1 | 2019 | 478 | 0.130 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 1156 | 0.130 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 667 | 0.130 |
Why?
|
Hospitals | 2 | 2020 | 3882 | 0.130 |
Why?
|
Referral and Consultation | 2 | 2019 | 3600 | 0.130 |
Why?
|
Catheters | 1 | 2018 | 427 | 0.130 |
Why?
|
Boston | 2 | 2019 | 9326 | 0.130 |
Why?
|
ROC Curve | 2 | 2020 | 3579 | 0.120 |
Why?
|
Aged, 80 and over | 7 | 2024 | 58986 | 0.120 |
Why?
|
Echocardiography, Doppler | 1 | 2019 | 897 | 0.120 |
Why?
|
Retrospective Studies | 7 | 2021 | 80646 | 0.120 |
Why?
|
Cardiovascular System | 1 | 2022 | 834 | 0.120 |
Why?
|
Angina, Unstable | 1 | 2019 | 888 | 0.120 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7827 | 0.120 |
Why?
|
Hospital Costs | 1 | 2021 | 947 | 0.120 |
Why?
|
Primary Prevention | 2 | 2019 | 1186 | 0.120 |
Why?
|
Myocardial Revascularization | 1 | 2018 | 790 | 0.120 |
Why?
|
Models, Economic | 1 | 2018 | 716 | 0.120 |
Why?
|
Adiponectin | 1 | 2020 | 1113 | 0.120 |
Why?
|
Electrocardiography | 2 | 2019 | 6377 | 0.110 |
Why?
|
China | 1 | 2020 | 2374 | 0.110 |
Why?
|
United States Food and Drug Administration | 2 | 2019 | 1664 | 0.110 |
Why?
|
Physicians, Women | 1 | 2019 | 509 | 0.110 |
Why?
|
Drug Industry | 1 | 2020 | 788 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5841 | 0.110 |
Why?
|
Tetrazoles | 1 | 2019 | 909 | 0.110 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2016 | 481 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 12148 | 0.100 |
Why?
|
Time Factors | 3 | 2020 | 39970 | 0.100 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12975 | 0.100 |
Why?
|
Disclosure | 1 | 2018 | 748 | 0.100 |
Why?
|
Treatment Outcome | 6 | 2019 | 64684 | 0.100 |
Why?
|
Coronary Occlusion | 1 | 2015 | 304 | 0.100 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2019 | 1050 | 0.100 |
Why?
|
Telemedicine | 2 | 2019 | 3052 | 0.100 |
Why?
|
Coronary Artery Bypass | 1 | 2021 | 2188 | 0.100 |
Why?
|
Myocardial Ischemia | 1 | 2022 | 2113 | 0.100 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39107 | 0.090 |
Why?
|
Mortality | 2 | 2019 | 2901 | 0.090 |
Why?
|
Blood Pressure | 2 | 2024 | 8481 | 0.090 |
Why?
|
Cholesterol, HDL | 1 | 2017 | 1814 | 0.090 |
Why?
|
Outpatients | 1 | 2018 | 1597 | 0.090 |
Why?
|
Program Evaluation | 1 | 2019 | 2495 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1809 | 0.090 |
Why?
|
Stroke Volume | 2 | 2021 | 5496 | 0.090 |
Why?
|
Thrombectomy | 1 | 2015 | 705 | 0.090 |
Why?
|
Income | 1 | 2018 | 1877 | 0.080 |
Why?
|
Contrast Media | 2 | 2022 | 5311 | 0.080 |
Why?
|
Bariatric Surgery | 1 | 2019 | 992 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20099 | 0.080 |
Why?
|
Hypoglycemic Agents | 2 | 2019 | 3085 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1670 | 0.080 |
Why?
|
Radiation Injuries | 1 | 2016 | 1189 | 0.080 |
Why?
|
Odds Ratio | 2 | 2018 | 9646 | 0.080 |
Why?
|
Databases, Factual | 2 | 2021 | 7967 | 0.080 |
Why?
|
Death, Sudden, Cardiac | 1 | 2017 | 1555 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 3879 | 0.080 |
Why?
|
Obesity, Morbid | 1 | 2019 | 1277 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1792 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7237 | 0.080 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2917 | 0.080 |
Why?
|
Cohort Studies | 3 | 2019 | 41493 | 0.070 |
Why?
|
Cholesterol, LDL | 1 | 2017 | 2382 | 0.070 |
Why?
|
Survival Rate | 2 | 2019 | 12725 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4431 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 26127 | 0.070 |
Why?
|
Delirium | 1 | 2018 | 1668 | 0.070 |
Why?
|
Aortic Valve | 1 | 2016 | 1955 | 0.070 |
Why?
|
Health Expenditures | 1 | 2018 | 2366 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2373 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14666 | 0.060 |
Why?
|
Disease Progression | 2 | 2018 | 13510 | 0.060 |
Why?
|
Artificial Intelligence | 1 | 2019 | 2578 | 0.060 |
Why?
|
Smoking | 1 | 2021 | 9053 | 0.060 |
Why?
|
Cardiac Electrophysiology | 1 | 2024 | 59 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9469 | 0.060 |
Why?
|
Inflammation | 2 | 2022 | 10773 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12690 | 0.050 |
Why?
|
Registries | 1 | 2019 | 8224 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20571 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 15936 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 151 | 0.050 |
Why?
|
Obesity | 2 | 2022 | 12947 | 0.050 |
Why?
|
Censuses | 1 | 2022 | 202 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 22176 | 0.050 |
Why?
|
Cystatin C | 1 | 2022 | 270 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2019 | 5127 | 0.050 |
Why?
|
New England | 1 | 2024 | 1054 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10212 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2022 | 250 | 0.040 |
Why?
|
Osteopontin | 1 | 2022 | 301 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2015 | 4481 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9758 | 0.040 |
Why?
|
Vitamin K | 1 | 2022 | 318 | 0.040 |
Why?
|
Pharmacological Phenomena | 1 | 2019 | 11 | 0.040 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 8002 | 0.040 |
Why?
|
American Heart Association | 1 | 2022 | 1039 | 0.040 |
Why?
|
Animals | 3 | 2020 | 168467 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3422 | 0.040 |
Why?
|
Hemorrhage | 2 | 2019 | 3424 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2022 | 1733 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2281 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2019 | 676 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12463 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2020 | 1475 | 0.030 |
Why?
|
Diabetic Angiopathies | 1 | 2019 | 803 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2019 | 1007 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2927 | 0.030 |
Why?
|
Creatinine | 1 | 2019 | 1899 | 0.030 |
Why?
|
Catheterization | 1 | 2018 | 1428 | 0.030 |
Why?
|
Drug Utilization | 1 | 2019 | 1188 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2904 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2048 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 962 | 0.030 |
Why?
|
Radiography | 1 | 2024 | 6965 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3123 | 0.030 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 840 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1039 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3208 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1668 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2192 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4021 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2019 | 6228 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2022 | 3807 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2177 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2021 | 2091 | 0.020 |
Why?
|
Heart Valve Diseases | 1 | 2016 | 1027 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2019 | 1940 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8466 | 0.020 |
Why?
|
Health Promotion | 1 | 2019 | 2214 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10766 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9319 | 0.020 |
Why?
|
Algorithms | 1 | 2024 | 14032 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12954 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5336 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36429 | 0.010 |
Why?
|
Adult | 1 | 2019 | 221203 | 0.000 |
Why?
|